Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era.
Tadmor T, Bari A, Sacchi S, Marcheselli L, Liardo EV, Avivi I, Benyamini N, Attias D, Pozzi S, Cox MC, Baldini L, Brugiatelli M, Federico M, Polliack A. Tadmor T, et al. Among authors: liardo ev. Haematologica. 2014 Jan;99(1):125-30. doi: 10.3324/haematol.2013.088161. Epub 2013 Aug 9. Haematologica. 2014. PMID: 23935023 Free PMC article.
Defining the best cut-off value for lymphopenia in diffuse large B cell lymphoma treated with immuno-chemotherapy.
Bari A, Tadmor T, Sacchi S, Marcheselli L, Cox C, Liardo EV, Pozzi S, Benyamini N, Avivi I, Ferrari A, Baldini L, Falorio S, Gobbi P, Federico M, Polliack A. Bari A, et al. Among authors: liardo ev. Br J Haematol. 2014 Oct;167(1):133-6. doi: 10.1111/bjh.12930. Epub 2014 May 3. Br J Haematol. 2014. PMID: 24797533 Free article. No abstract available.
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial.
Iannitto E, Minardi V, Gobbi PG, Calvaruso G, Tripodo C, Marcheselli L, Luminari S, Merli F, Baldini L, Stelitano C, Callea V, Petrini M, Angrilli F, Quarta G, Vallisa D, Molica S, Liardo E, Polimeno G, Brugiatelli M, Federico M. Iannitto E, et al. Clin Lymphoma Myeloma. 2009 Apr;9(2):138-44. doi: 10.3816/CLM.2009.n.034. Clin Lymphoma Myeloma. 2009. PMID: 19406724 Clinical Trial.
Therapy-related myeloid neoplasm in non-hodgkin lymphoma survivors.
Bari A, Marcheselli L, Marcheselli R, Liardo EV, Pozzi S, Ferri P, Sacchi S. Bari A, et al. Among authors: liardo ev. Mediterr J Hematol Infect Dis. 2011;3(1):e2011065. doi: 10.4084/MJHID.2011.065. Epub 2011 Dec 20. Mediterr J Hematol Infect Dis. 2011. PMID: 22220262 Free PMC article.
Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL).
Di Renzo N, Montanini A, Mannina D, Dondi A, Muci S, Mancuso S, De Paolis MR, Plati C, Stelitano C, Patti C, Olivieri A, Liardo E, Buda G, Cantaffa R, Federico M. Di Renzo N, et al. Support Care Cancer. 2011 Oct;19(10):1505-10. doi: 10.1007/s00520-010-0974-y. Epub 2010 Aug 8. Support Care Cancer. 2011. PMID: 20694798 Free PMC article. Clinical Trial.
13 results